Literature DB >> 9614234

Dopamine neurons make glutamatergic synapses in vitro.

D Sulzer1, M P Joyce, L Lin, D Geldwert, S N Haber, T Hattori, S Rayport.   

Abstract

Interactions between dopamine and glutamate play prominent roles in memory, addiction, and schizophrenia. Several lines of evidence have suggested that the ventral midbrain dopamine neurons that give rise to the major CNS dopaminergic projections may also be glutamatergic. To examine this possibility, we double immunostained ventral midbrain sections from rat and monkey for the dopamine-synthetic enzyme tyrosine hydroxylase and for glutamate; we found that most dopamine neurons immunostained for glutamate, both in rat and monkey. We then used postnatal cell culture to examine individual dopamine neurons. Again, most dopamine neurons immunostained for glutamate; they were also immunoreactive for phosphate-activated glutaminase, the major source of neurotransmitter glutamate. Inhibition of glutaminase reduced glutamate staining. In single-cell microculture, dopamine neurons gave rise to varicosities immunoreactive for both tyrosine hydroxylase and glutamate and others immunoreactive mainly for glutamate, which were found near the cell body. At the ultrastructural level, dopamine neurons formed occasional dopaminergic varicosities with symmetric synaptic specializations, but they more commonly formed nondopaminergic varicosities with asymmetric synaptic specializations. Stimulation of individual dopamine neurons evoked a fast glutamatergic autaptic EPSC that showed presynaptic inhibition caused by concomitant dopamine release. Thus, dopamine neurons may exert rapid synaptic actions via their glutamatergic synapses and slower modulatory actions via their dopaminergic synapses. Together with evidence for glutamate cotransmission in serotonergic raphe neurons and noradrenergic locus coeruleus neurons, the present results suggest that glutamatergic cotransmission may be the rule for central monoaminergic neurons.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9614234      PMCID: PMC6792695     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  68 in total

1.  Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum.

Authors:  S J Cragg; S A Greenfield
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

2.  Ultrastructural localization of tyrosine hydroxylase in the rat ventral tegmental area: relationship between immunolabeling density and neuronal associations.

Authors:  V E Bayer; V M Pickel
Journal:  J Neurosci       Date:  1990-09       Impact factor: 6.167

3.  Regional distribution of the messenger RNA coding for the neuropeptide cholecystokinin in the human brain examined by in situ hybridization.

Authors:  M Savasta; J M Palacios; G Mengod
Journal:  Brain Res Mol Brain Res       Date:  1990-02

4.  5-hydroxydopamine-labeled dopaminergic axons: three-dimensional reconstructions of axons, synapses and postsynaptic targets in rat neostriatum.

Authors:  P M Groves; J C Linder; S J Young
Journal:  Neuroscience       Date:  1994-02       Impact factor: 3.590

Review 5.  Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates.

Authors:  B Berger; P Gaspar; C Verney
Journal:  Trends Neurosci       Date:  1991-01       Impact factor: 13.837

6.  Dissociated high-purity dopaminergic neuron cultures from the substantia nigra and the ventral tegmental area of the postnatal rat.

Authors:  S Masuko; S Nakajima; Y Nakajima
Journal:  Neuroscience       Date:  1992-07       Impact factor: 3.590

7.  Identified postnatal mesolimbic dopamine neurons in culture: morphology and electrophysiology.

Authors:  S Rayport; D Sulzer; W X Shi; S Sawasdikosol; J Monaco; D Batson; G Rajendran
Journal:  J Neurosci       Date:  1992-11       Impact factor: 6.167

8.  Glutamate as a CNS transmitter. I. Evaluation of glucose and glutamine as precursors for the synthesis of preferentially released glutamate.

Authors:  A C Hamberger; G H Chiang; E S Nylén; S W Scheff; C W Cotman
Journal:  Brain Res       Date:  1979-06-08       Impact factor: 3.252

9.  Glutamate- and GABA-containing neurons in the mouse and rat brain, as demonstrated with a new immunocytochemical technique.

Authors:  O P Ottersen; J Storm-Mathisen
Journal:  J Comp Neurol       Date:  1984-11-01       Impact factor: 3.215

10.  On the potassium conductance increase activated by GABAB and dopamine D2 receptors in rat substantia nigra neurones.

Authors:  M G Lacey; N B Mercuri; R A North
Journal:  J Physiol       Date:  1988-07       Impact factor: 5.182

View more
  133 in total

1.  Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size.

Authors:  E N Pothos; K E Larsen; D E Krantz; Y Liu; J W Haycock; W Setlik; M D Gershon; R H Edwards; D Sulzer
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

2.  Vesicular monoamine and glutamate transporters select distinct synaptic vesicle recycling pathways.

Authors:  Bibiana Onoa; Haiyan Li; Johann A Gagnon-Bartsch; Laura A B Elias; Robert H Edwards
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

Review 3.  Glutamatergic signaling by midbrain dopaminergic neurons: recent insights from optogenetic, molecular and behavioral studies.

Authors:  Tibor Koos; Fatuel Tecuapetla; James M Tepper
Journal:  Curr Opin Neurobiol       Date:  2011-05-31       Impact factor: 6.627

4.  GABAergic synapses made by a retinal dopaminergic neuron.

Authors:  Massimo Contini; Elio Raviola
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-23       Impact factor: 11.205

5.  Homeostatic regulation of dopaminergic neurons without dopamine.

Authors:  D James Surmeier
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-30       Impact factor: 11.205

6.  Glutamatergic signaling by mesolimbic dopamine neurons in the nucleus accumbens.

Authors:  Fatuel Tecuapetla; Jyoti C Patel; Harry Xenias; Daniel English; Ibrahim Tadros; Fulva Shah; Joshua Berlin; Karl Deisseroth; Margaret E Rice; James M Tepper; Tibor Koos
Journal:  J Neurosci       Date:  2010-05-19       Impact factor: 6.167

7.  Loss of neurotensin receptor-1 disrupts the control of the mesolimbic dopamine system by leptin and promotes hedonic feeding and obesity.

Authors:  Darren Opland; Amy Sutton; Hillary Woodworth; Juliette Brown; Raluca Bugescu; Adriana Garcia; Lyndsay Christensen; Christopher Rhodes; Martin Myers; Gina Leinninger
Journal:  Mol Metab       Date:  2013-08-07       Impact factor: 7.422

Review 8.  Dual-transmitter neurons: functional implications of co-release and co-transmission.

Authors:  Christopher E Vaaga; Maria Borisovska; Gary L Westbrook
Journal:  Curr Opin Neurobiol       Date:  2014-05-13       Impact factor: 6.627

Review 9.  Heterogeneity in Dopamine Neuron Synaptic Actions Across the Striatum and Its Relevance for Schizophrenia.

Authors:  Nao Chuhma; Susana Mingote; Abigail Kalmbach; Leora Yetnikoff; Stephen Rayport
Journal:  Biol Psychiatry       Date:  2016-07-12       Impact factor: 13.382

10.  Nicotine and ethanol cooperate to enhance ventral tegmental area AMPA receptor function via α6-containing nicotinic receptors.

Authors:  Staci E Engle; J Michael McIntosh; Ryan M Drenan
Journal:  Neuropharmacology       Date:  2014-12-04       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.